Newborn genetic screening for spinal muscular atrophy in the UK: The views of the general population.
Felicity K BoardmanChloe SadlerPhilip J YoungPublished in: Molecular genetics & genomic medicine (2017)
Public acceptability is a key component in the evaluation of any potential screening program in the UK. This study demonstrates that newborn screening for SMA is viewed largely positively by people unfamiliar with the condition. The importance of early identification overrode all other social and ethical concerns about screening for the majority of participants.